L-2-Aminobutanedioic acid
Brand names,
L-2-Aminobutanedioic acid
Analogs
L-2-Aminobutanedioic acid
Brand Names Mixture
L-2-Aminobutanedioic acid
Chemical_Formula
C4H7N1O4
L-2-Aminobutanedioic acid
RX_link
No information avaliable
L-2-Aminobutanedioic acid
fda sheet
L-2-Aminobutanedioic acid
msds (material safety sheet)
L-2-Aminobutanedioic acid
Synthesis Reference
No information avaliable
L-2-Aminobutanedioic acid
Molecular Weight
133.104 g/mol
L-2-Aminobutanedioic acid
Melting Point
230 oC
L-2-Aminobutanedioic acid
H2O Solubility
4.5 g/l
L-2-Aminobutanedioic acid
State
Solid
L-2-Aminobutanedioic acid
LogP
-0.67 +/- 0.36
L-2-Aminobutanedioic acid
Dosage Forms
Capsules and powder
L-2-Aminobutanedioic acid
Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
L-2-Aminobutanedioic acid
Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
L-2-Aminobutanedioic acid
Absorption
Absorbed from the small intestine by an active transport process
L-2-Aminobutanedioic acid
side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
L-2-Aminobutanedioic acid
Patient Information
No information avaliable
L-2-Aminobutanedioic acid
Organisms Affected
Humans and other mammals